The life sciences sector experienced an explosive boom during the pandemic’s early phase, followed by a slight cooling in funding in 2022. Despite this, the Barnes & Thornburg law firm’s 2023 Investment Funds Outlook report indicates that opportunities within the sector remain plentiful. John E. Kelly, a partner in the firm and chair of the…